• 69 Citations
  • 4 h-Index
20172017
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gianluca Ametrano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Endocrine Gland Neoplasms Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Endocrine Disruptors Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cell Biology Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2017

  • 69 Citations
  • 4 h-Index
  • 4 Review article
  • 3 Article
11 Citations (Scopus)

Metabolic syndrome, endocrine disruptors and prostate cancer associations: Biochemical and pathophysiological evidences

Quagliariello, V., Rossetti, S., Cavaliere, C., Di Palo, R., Lamantia, E., Castaldo, L., Nocerino, F., Ametrano, G., Cappuccio, F., Malzone, G., Montanari, M., Vanacore, D., Romano, F. J., Piscitelli, R., Iovane, G., Pepe, M. F., Berretta, M., D'Aniello, C., Perdonà, S., Muto, P. & 9 others, Botti, G., Ciliberto, G., Veneziani, B. M., De Falco, F., Maiolino, P., Caraglia, M., Montella, M., Iaffaioli, R. V. & Facchini, G., 2017, In : Oncotarget. 8, 18, p. 30606-30616 11 p.

Research output: Contribution to journalReview article

Endocrine Gland Neoplasms
Endocrine Disruptors
Prostatic Neoplasms
Tumor Suppressor Proteins
Recurrence

Metabolic syndrome, endocrine disruptors and prostate cancer associations: Biochemical and pathophysiological evidences

Quagliariello, V., Rossetti, S., Cavaliere, C., Di Palo, R., Lamantia, E., Castaldo, L., Nocerino, F., Ametrano, G., Cappuccio, F., Malzone, G., Montanari, M., Vanacore, D., Romano, F. J., Piscitelli, R., Iovane, G., Pepe, M. F., Berretta, M., D'Aniello, C., Perdonà, S., Muto, P. & 9 others, Botti, G., Ciliberto, G., Veneziani, B. M., De Falco, F., Maiolino, P., Caraglia, M., Montella, M., Iaffaioli, R. V. & Facchini, G., 2017, In : Oncotarget. 8, 18, p. 30606-30616 11 p.

Research output: Contribution to journalArticle

Endocrine Gland Neoplasms
Endocrine Disruptors
Prostatic Neoplasms
Tumor Suppressor Proteins
Recurrence
33 Citations (Scopus)

Micrornas in prostate cancer: an overview

Vanacore, D., Boccellino, M., Rossetti, S., Cavaliere, C., D'Aniello, C., Di Franco, R., Romano, F. J., Montanari, M., La Mantia, E., Piscitelli, R., Nocerino, F., Cappuccio, F., Grimaldi, G., Izzo, A., Castaldo, L., Pepe, M. F., Malzone, M. G., Iovane, G., Ametrano, G., Stiuso, P. & 10 others, Quagliuolo, L., Barberio, D., Perdonà, S., Muto, P., Montella, M., Maiolino, P., Veneziani, B. M., Botti, G., Caraglia, M. & Facchini, G., Jul 2017, In : Oncotarget.

Research output: Contribution to journalReview article

MicroRNAs
Prostatic Neoplasms
Neoplasms
Biological Phenomena
Oncogenes

ProEx C as diagnostic marker for detection of urothelial carcinoma in urinary samples: A review

Botti, G., Malzone, M. G., La Mantia, E., Montanari, M., Vanacore, D., Rossetti, S., Quagliariello, V., Cavaliere, C., Di Franco, R., Castaldo, L., Ametrano, G., Cappuccio, F., Romano, F. J., Piscitelli, R., Pepe, M. F., D’Aniello, C. & Facchini, G., Apr 21 2017, In : International Journal of Medical Sciences. 14, 6, p. 554-559 6 p.

Research output: Contribution to journalReview article

Cell Biology
Carcinoma
Minichromosome Maintenance Proteins
Urine
Type II DNA Topoisomerase

Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis

Di Franco, R., Borzillo, V., Ravo, V., Ametrano, G., Cammarota, F., Rossetti, S., Romano, F. J., D'Aniello, C., Cavaliere, C., Iovane, G., Porricelli, M. A., Muto, M., Berretta, M., Facchini, G. & Muto, P., Aug 2017, In : European Review for Medical and Pharmacological Sciences. 21, 16, p. 3563-3575 13 p.

Research output: Contribution to journalArticle

Meta-Analysis
Prostatic Neoplasms
Radiotherapy
Odds Ratio
Technology